✦ LIBER ✦

T1181 Surgery Rate in Patients with Crohn's Disease with Regard to Long-Term Clinical Outcome of Infliximab Treatment

✍ Scribed by Pedersen, Natalia; Duricova, Dana; Lenicek, Martin; Elkjaer, Margarita; Lukas, Milan; Munkholm, Pia S.

Book ID: 123256638
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 55 KB
Volume: 134
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(08)62340-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P226 SURGERY RATE IN PATIENTS WITH CROHN

P226 SURGERY RATE IN PATIENTS WITH CROHN'S DISEASE WITH REGARD TO LONG-TERM CLINICAL OUTCOME OF INFLIXIMAB TREATMENT

✍ N. Pedersen; D. Duricova; M. Lenicek; M. Elkjaer; M. Lukas; P. Munkholm 📂 Article 📅 2008 🏛 Oxford University Press ⚖ 75 KB

P430 Long-term outcome of Crohn's diseas

P430 Long-term outcome of Crohn's disease patients treated with infliximab

✍ Chen, B.L.; Lv, S.C.; Feng, T.; Li, M.Y.; Rao, P.S.; Zeng, Z.R.; Hu, P.J.; Chen, 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 51 KB

Persistent fistula tracks in perianal Cr

Persistent fistula tracks in perianal Crohn's disease after long term infliximab treatment: Correlation with clinical outcome

✍ Gert A. Van Assche; Dirk Vanbeckevoort; Didier Bielen; Geert D'Haens; Andre D'Ho 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 167 KB

The impact of infliximab infusion reacti

The impact of infliximab infusion reactions on long-term outcomes in patients with Crohn’s disease

✍ A. C. MOSS; N. FERNANDEZ-BECKER; K. JO KIM; D. CURY; A. S. CHEIFETZ 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

LONG-TERM OUTCOME OF TREATMENT WITH INFL

LONG-TERM OUTCOME OF TREATMENT WITH INFLIXIMAB IN 440 CROHN'S DISEASE PATIENTS: RESULTS FROM A SINGLE CENTER COHORT

✍ F. Schnitzler; H. Fidder; M. Ferrante; M. Noman; G. Van Assche; I. Hoffman; S. V 📂 Article 📅 2007 🏛 Oxford University Press ⚖ 96 KB

Long-term outcome of treatment with infl

Long-term outcome of treatment with infliximab in pediatric-onset Crohn's disease: A population-based study

✍ Valérie Crombé; Julia Salleron; Guillaume Savoye; Jean-Louis Dupas; Gwénola Vern 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 549 KB

Background: We examined short-and long-term benefits and safety of infliximab (IFX) in a population-based cohort of Crohn's disease (CD) patients <17 years old at diagnosis. ## Methods: The following parameters were assessed: short-and long-term efficacy of IFX, impact of drug efficacy, and mode